Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Century Therapeutics, Inc. (IPSC) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Century Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1850119.
Total stock buying since 2021: $17,007,655.
Total stock sales since 2021: $8,142,251.
Total stock option exercises since 2021: $424,042.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 81,935 | $54,344 | 0 | $0 |
| 2024 | 5,000 | $7,655 | 89,970 | $381,484 | 54,000 | $55,618 |
| 2023 | 0 | $0 | 144,911 | $539,923 | 357,696 | $368,424 |
| 2022 | 0 | $0 | 550,000 | $7,166,500 | 0 | $0 |
| 2021 | 850,000 | $17,000,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 296 | $158 | 0 | $0 |
| 2025-06 | 0 | $0 | 6,457 | $4,015 | 0 | $0 |
| 2025-05 | 0 | $0 | 30,871 | $16,860 | 0 | $0 |
| 2025-03 | 0 | $0 | 8,194 | $5,037 | 0 | $0 |
| 2025-02 | 0 | $0 | 36,117 | $28,274 | 0 | $0 |
| 2024-11 | 0 | $0 | 1,033 | $1,267 | 0 | $0 |
| 2024-09 | 5,000 | $7,655 | 0 | $0 | 0 | $0 |
| 2024-08 | 0 | $0 | 1,362 | $2,488 | 0 | $0 |
| 2024-07 | 0 | $0 | 2,386 | $5,993 | 0 | $0 |
| 2024-06 | 0 | $0 | 10,000 | $29,170 | 0 | $0 |
| 2024-05 | 0 | $0 | 11,170 | $34,233 | 0 | $0 |
| 2024-04 | 0 | $0 | 5,000 | $15,490 | 0 | $0 |
| 2024-03 | 0 | $0 | 53,515 | $269,697 | 53,515 | $55,119 |
| 2024-02 | 0 | $0 | 5,504 | $23,146 | 485 | $499 |
| 2023-04 | 0 | $0 | 0 | $0 | 7,452 | $7,675 |
| 2023-03 | 0 | $0 | 144,911 | $539,923 | 350,244 | $360,749 |
| 2022-08 | 0 | $0 | 550,000 | $7,166,500 | 0 | $0 |
| 2021-06 | 850,000 | $17,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-04 | Carr Douglas (SVP Finance & Operations) | Sale | 296 | .53 | 158 |
| 2025-06-09 | Pfeiffenberger Brent (President and CEO) | Sale | 475 | .62 | 295 |
| 2025-06-09 | Farid Adrienne (Chief Operations Officer) | Sale | 552 | .62 | 343 |
| 2025-06-09 | Russotti Gregory (See Remarks) | Sale | 526 | .62 | 327 |
| 2025-06-09 | Carr Douglas (SVP Finance & Operations) | Sale | 4,904 | .62 | 3,050 |
| 2025-05-16 | Pfeiffenberger Brent (President and CEO) | Sale | 29,552 | .55 | 16,135 |
| 2025-05-05 | Farid Adrienne (Chief Operations Officer) | Sale | 1,024 | .55 | 563 |
| 2025-05-05 | Carr Douglas (SVP Finance & Operations) | Sale | 295 | .55 | 162 |
| 2025-03-10 | Pfeiffenberger Brent (President and CEO) | Sale | 2,235 | .61 | 1,374 |
| 2025-03-10 | Farid Adrienne (Chief Operations Officer) | Sale | 2,359 | .61 | 1,450 |
| 2025-03-10 | Russotti Gregory (See Remarks) | Sale | 2,360 | .61 | 1,451 |
| 2025-03-10 | Carr Douglas (SVP Finance & Operations) | Sale | 1,240 | .61 | 762 |
| 2025-02-18 | Pfeiffenberger Brent (President and CEO) | Sale | 34,712 | .78 | 27,179 |
| 2025-02-03 | Farid Adrienne (Chief Operations Officer) | Sale | 1,054 | .78 | 822 |
| 2025-02-03 | Carr Douglas (SVP Finance & Operations) | Sale | 351 | .78 | 273 |
| 2024-11-04 | Farid Adrienne (Chief Operations Officer) | Sale | 1,033 | 1.23 | 1,267 |
| 2024-09-12 | Quimi Daphne (Director) | Buy | 5,000 | 1.53 | 7,655 |
| 2024-08-05 | Farid Adrienne (Chief Operations Officer) | Sale | 1,073 | 1.83 | 1,960 |
| 2024-08-05 | Carr Douglas (SVP Finance & Operations) | Sale | 289 | 1.83 | 528 |
| 2024-07-26 | Russotti Gregory (See Remarks) | Sale | 586 | 2.50 | 1,465 |
| 2024-07-24 | Russotti Gregory (See Remarks) | Sale | 1,600 | 2.52 | 4,028 |
| 2024-07-23 | Russotti Gregory (See Remarks) | Sale | 200 | 2.50 | 500 |
| 2024-06-20 | Russotti Gregory (See Remarks) | Sale | 5,000 | 2.84 | 14,180 |
| 2024-06-05 | Russotti Gregory (See Remarks) | Sale | 5,000 | 3.00 | 14,990 |
| 2024-05-20 | Russotti Gregory (See Remarks) | Sale | 5,000 | 3.00 | 14,980 |
| 2024-05-06 | Russotti Gregory (See Remarks) | Sale | 5,000 | 3.12 | 15,620 |
| 2024-05-03 | Farid Adrienne (Chief Operations Officer) | Sale | 913 | 3.11 | 2,835 |
| 2024-05-03 | Carr Douglas (SVP Finance & Operations) | Sale | 257 | 3.11 | 798 |
| 2024-04-22 | Russotti Gregory (See Remarks) | Sale | 5,000 | 3.10 | 15,490 |
| 2024-03-07 | Farid Adrienne (Chief Operations Officer) | Sale | 22,831 | 5.14 | 117,351 |
| 2024-03-07 | Farid Adrienne (Chief Operations Officer) | Option Ex | 22,831 | 1.03 | 23,515 |
| 2024-03-06 | Farid Adrienne (Chief Operations Officer) | Sale | 30,684 | 4.96 | 152,346 |
| 2024-03-06 | Farid Adrienne (Chief Operations Officer) | Option Ex | 30,684 | 1.03 | 31,604 |
| 2024-02-16 | Farid Adrienne (Chief Operations Officer) | Sale | 485 | 4.86 | 2,358 |
| 2024-02-16 | Farid Adrienne (Chief Operations Officer) | Option Ex | 485 | 1.03 | 499 |
| 2024-02-06 | Farid Adrienne (Chief Operations Officer) | Sale | 1,784 | 4.49 | 8,004 |
| 2024-02-06 | Carr Douglas (SVP Finance & Operations) | Sale | 557 | 4.49 | 2,499 |
| 2024-02-05 | Farid Adrienne (Chief Operations Officer) | Sale | 2,035 | 3.84 | 7,816 |
| 2024-02-05 | Carr Douglas (SVP Finance & Operations) | Sale | 643 | 3.84 | 2,469 |
| 2023-04-03 | Borges Luis (Chief Scientific Officer) | Option Ex | 7,452 | 1.03 | 7,675 |
| 2023-03-23 | Borges Luis (Chief Scientific Officer) | Sale | 15,597 | 3.55 | 55,369 |
| 2023-03-23 | Borges Luis (Chief Scientific Officer) | Option Ex | 220,930 | 1.03 | 227,557 |
| 2023-03-22 | Borges Luis (Chief Scientific Officer) | Sale | 65,698 | 3.72 | 244,659 |
| 2023-03-22 | Borges Luis (Chief Scientific Officer) | Option Ex | 65,698 | 1.03 | 67,668 |
| 2023-03-21 | Borges Luis (Chief Scientific Officer) | Sale | 63,616 | 3.77 | 239,895 |
| 2023-03-21 | Borges Luis (Chief Scientific Officer) | Option Ex | 63,616 | 1.03 | 65,524 |
| 2022-08-09 | Versant Vantage Ii Gp-gp, Llc (10% Owner) | Sale | 550,000 | 13.03 | 7,166,500 |
| 2021-06-22 | Versant Vantage Ii Gp-gp, Llc | Buy | 100,000 | 20.00 | 2,000,000 |
| 2021-06-22 | Casdin Eli | Buy | 750,000 | 20.00 | 15,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IPSC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Century Therapeutics, Inc. (symbol IPSC, CIK number 1850119) see the Securities and Exchange Commission (SEC) website.